American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment

INTRODUCTIONSection:The American Society of Clinical Oncology (ASCO) represents more than 35,000 oncologists and other health care professionals who care for people with cancer and conduct research to improve cancer treatment. ASCO approved a policy statement on the importance of phase I trials in cancer treatment in 1996 and published it in 1997.1 ASCO and its member clinicians have repeatedly…

Read the full article here

Source: Journal of Clinical Oncology

Categories: Hem/Oncs

Tags: OncoAlert

Tweets with this article

Raul Cordoba, MD, PhD

#OncoAlert American Society of Clinical Oncology ⁦@ASCO⁩ Policy Statement Update: The Critical Role of Phase I Trials in #Cancer #Research and Treatment | #clinicaltrials https://t.co/TfufC7TwGC

Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes

Not available.

Raul Cordoba, MD, PhD January 23, 2025

Bispecific antibodies: advancing precision oncology

Bispecific antibodies (bsAbs) are engineered molecules designed to target two different epitopes or antigens. The mechanism of action is determined by the bsAb molecular targets…

Raul Cordoba, MD, PhD January 19, 2025

Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System

Dupilumab, a mAb targeting the IL-4Rα subunit, emerged in 2017 as a promising intervention for atopic dermatitis (AD). Three clinical trials led to dupilumab’s approval;…

Raul Cordoba, MD, PhD January 17, 2025

Related Articles